Herceptin News and Research

RSS
New strategy involving three-pronged approach may keep lung cancer aside

New strategy involving three-pronged approach may keep lung cancer aside

Palbociclib drug shows promise in women with HR+ metastatic breast cancer

Palbociclib drug shows promise in women with HR+ metastatic breast cancer

Researchers identify molecular switch for protein that causes HER2-positive breast cancer

Researchers identify molecular switch for protein that causes HER2-positive breast cancer

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Imperial scientists develop new test that uses human stem cells to predict side effects of drugs

Imperial scientists develop new test that uses human stem cells to predict side effects of drugs

Actavis provides overview of standalone global pharmaceutical development pipeline

Actavis provides overview of standalone global pharmaceutical development pipeline

Scientists develop potential new therapy based on cow's immune molecules for hormone deficiencies

Scientists develop potential new therapy based on cow's immune molecules for hormone deficiencies

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

New drug gets FDA approval for treatment of women with advanced breast cancer

New drug gets FDA approval for treatment of women with advanced breast cancer

Combination therapy can reduce recurrence of small, HER2-positive breast tumors

Combination therapy can reduce recurrence of small, HER2-positive breast tumors

Trastuzumab drug improves long-term survival of patients with HER-2 positive breast cancer

Trastuzumab drug improves long-term survival of patients with HER-2 positive breast cancer

Commonly used osteoporosis medications may also prevent lung, breast and colon cancers

Commonly used osteoporosis medications may also prevent lung, breast and colon cancers

Research findings point toward new therapeutic target for aggressive breast cancer

Research findings point toward new therapeutic target for aggressive breast cancer

Open payments database debuts, detailing financial connections between physicians and drug makers

Open payments database debuts, detailing financial connections between physicians and drug makers

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

Halozyme reports revenues of $18.4 million, net loss of $16.3 million for Q2 2014

Halozyme reports revenues of $18.4 million, net loss of $16.3 million for Q2 2014

Scientists discover important new biomarker that could improve HER2 targeted cancer treatments

Scientists discover important new biomarker that could improve HER2 targeted cancer treatments